Delving into the Latest Updates on PPD Australia Pty Ltd. with Synapse

Overview

Tags

Immune System Diseases

Hemic and Lymphatic Diseases

Neoplasms

Enzyme

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Enzyme	1

Top 5 Target	Count

ASN(Asparagine)	1

A Randomized, Double-Blind, Parallel group, Comparative Phase I study for the assessment of Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of BP16 versus US licensed - Prolia® and EU approved - Prolia® Following a Single dose (60mg/mL) Subcutaneous Administration in Healthy Male Volunteers

Start Date26 Jun 2023

Sponsor / Collaborator

Curateq Biologics Pvt Ltd.

[+1]

NCT04035278

/ CompletedPhase 1

A Phase 1, Double Blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Dengusiil in Healthy Adults

This is a Phase 1 study to assess safety and tolerability of a single subcutaneous dose of Dengusiil in healthy adults of 18 to 45 years of age. In this study, immune response to Dengusiil will also be assessed over a period of 6 months and vaccine viremia will also be assessed over a period of 12 days after administration of vaccine.

Start Date17 Dec 2019

Sponsor / Collaborator

Serum Institute of India Pvt Ltd.

[+1]

ACTRN12609000708257

/ SuspendedPhase 2

A Randomized Open Label Study Comparing the Efficacy, Safety and Tolerability of Oral Administration of Amantadine and Ribavirin and Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects.

Start Date01 Aug 2009

Sponsor / Collaborator

Adamas Pharmaceuticals LLC

[+1]

100 Clinical Results associated with PPD Australia Pty Ltd.

Login to view more data

0 Patents (Medical) associated with PPD Australia Pty Ltd.

Login to view more data

100 Deals associated with PPD Australia Pty Ltd.

Login to view more data

100 Translational Medicine associated with PPD Australia Pty Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data